drugset / Trial / NCT00080327
Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia
Phase 4
Completed
370 enrolled
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka America Pharmaceutical · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
A study to evaluate three doses of aripiprazole versus placebo in patients with an acute episode of schizophrenia
Timeline
- Start
- 2003-11
- Primary completion
- 2004-09
- Completion
- 2004-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aripiprazole | Other / unclassified | 2 mg | Oral |
| Comparator | Aripiprazole | Other / unclassified | 5 mg | Oral |
| Comparator | Aripiprazole | Other / unclassified | 10 mg | Oral |